Medical researchers have discovered novel antivirulence drugs that, without killing the bacteria, render Methicillin Resistant Staphylococcus Aureus (MRSA) and Streptococcus pyogenes, commonly ...

Researchers have described how the protein that allows strep and staph bacteria to stick to human cells is prepared and packaged. The research could facilitate the development of new antibiotics.

A research team at the University of Arizona College of Medicine–Tucson is developing a drug that works in combination with copper to kill bacteria, including those that cause MRSA, a type of staph ...